These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 12112223)

  • 1. Hallervorden-Spatz syndrome resembling a typical Tourette syndrome.
    Scarano V; Pellecchia MT; Filla A; Barone P
    Mov Disord; 2002 May; 17(3):618-20. PubMed ID: 12112223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult Hallervorden-Spatz syndrome simulating amyotrophic lateral sclerosis.
    Vasconcelos OM; Harter DH; Duffy C; McDonough B; Seidman JG; Seidman CE; Campbell WW
    Muscle Nerve; 2003 Jul; 28(1):118-22. PubMed ID: 12811783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tourettism, hemiballism and juvenile Parkinsonism: expanding the clinical spectrum of the neurodegeneration associated to pantothenate kinase deficiency (Hallervorden Spatz syndrome)].
    Carod-Artal FJ; Vargas AP; Marinho PB; Fernandes-Silva TV; Portugal D
    Rev Neurol; 2004 Feb 16-29; 38(4):327-31. PubMed ID: 14997456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration.
    Thomas M; Hayflick SJ; Jankovic J
    Mov Disord; 2004 Jan; 19(1):36-42. PubMed ID: 14743358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations.
    Sethi KD; Adams RJ; Loring DW; el Gammal T
    Ann Neurol; 1988 Nov; 24(5):692-4. PubMed ID: 3202617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome.
    Baumeister FA; Auer DP; Hörtnagel K; Freisinger P; Meitinger T
    Neuropediatrics; 2005 Jun; 36(3):221-2. PubMed ID: 15944911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optic atrophy as the presenting sign in Hallervorden-Spatz syndrome.
    Casteels I; Spileers W; Swinnen T; Demaerel P; Silberstein J; Casaer P; Missotten L
    Neuropediatrics; 1994 Oct; 25(5):265-7. PubMed ID: 7885538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pure akinesia: an unusual phenotype of Hallervorden-Spatz syndrome.
    Molinuevo JL; Martí MJ; Blesa R; Tolosa E
    Mov Disord; 2003 Nov; 18(11):1351-3. PubMed ID: 14639680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pantothenate kinase associated neurodegeneration (Hallervorden-Spatz syndrome).
    Kapoor S; Hortnagel K; Gogia S; Paul R; Malhotra V; Prakash A
    Indian J Pediatr; 2005 Mar; 72(3):261-3. PubMed ID: 15812126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hallervorden-Spatz syndrome in two siblings diagnosed by clinical features and magnetic resonance imaging.
    Tiamkao S; Nitinavakarn B; Jitpimolmard S
    J Med Assoc Thai; 2000 Dec; 83(12):1535-40. PubMed ID: 11253896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hallervorden-Spatz syndrome. Indicative findings in cranial computerized and magnetic resonance tomography for intra vitam diagnosis].
    Kurlemann G; Bongartz G; Kuchelmeister K; Palm DG
    Monatsschr Kinderheilkd; 1991 Sep; 139(9):626-8. PubMed ID: 1745254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hallervorden-Spatz syndrome: report of a case].
    Adamo Júnior J
    Arq Neuropsiquiatr; 1993 Mar; 51(1):130-3. PubMed ID: 8215921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Importance of magnetic resonance in the diagnosis of Hallervorden- Spatz disease: presentation of a case with familial history].
    Pérez Sempere A; Martínez Menéndez B; Villaverde Amundarain FJ; Calandre Hoenigsfeld L; Bermejo Pareja F
    Neurologia; 1990; 5(7):252-3. PubMed ID: 2288756
    [No Abstract]   [Full Text] [Related]  

  • 14. [Magnetic resonance tomography confirms the diagnosis of Hallervorden-Spatz disease].
    Scheer PJ; Perz A; Ebner F; Kratky-Dunitz M
    Padiatr Padol; 1988; 23(3):245-52. PubMed ID: 3186269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau-predominant-associated pathology in a sporadic late-onset Hallervorden-Spatz syndrome.
    Zarranz JJ; Gómez-Esteban JC; Atarés B; Lezcano E; Forcadas M
    Mov Disord; 2006 Jan; 21(1):107-11. PubMed ID: 16114023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Magnetic resonance diagnosis of Hallervorden-Spatz disease].
    Bonetti M; Prandini F; Gasparotti R; Pavia M; Crispino M; Pittiani F
    Radiol Med; 1994 Dec; 88(6):869-70. PubMed ID: 7878250
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hallervorden-Spatz syndrome in 2 Venezuelan patients].
    Peña JA; Prieto-Carrasquero M; González-Ferrer S
    Invest Clin; 1994 Jun; 35(2):105-14. PubMed ID: 7918758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hallervorden-Spatz disease with Lewy bodies].
    Antoine JC; Tommasi M; Chalumeau A; Jouvet-Telinge A; Bourrat C
    Rev Neurol (Paris); 1985; 141(12):806-9. PubMed ID: 3008295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hallervorden Spatz disease: MR imaging.
    Shah J; Patkar D; Patankar T; Krishnan A; Prasad S; Limdi J
    J Postgrad Med; 1999; 45(4):114-7. PubMed ID: 10734349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First cases in the Czech Republic of the Hallervorden-Spatz disease resulting from mutation in the pantothenate kinase 2 gene.
    Zumrová A; Krepelová A; Kyncl M; Maríková T; Prosková M; Cíbochová R; Sebronová V; Komárek V
    Neuro Endocrinol Lett; 2005 Jun; 26(3):213-8. PubMed ID: 15990724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.